derang
normal
cellular
homeostasi
protein
level
caus
consequ
initi
progress
pulmonari
diseas
relat
genotyp
infect
injuri
smoke
toxin
exposur
neoplasm
discuss
one
fundament
mechan
protein
homeostasi
ubiquitin
proteasom
system
up
relat
lung
diseas
up
effect
select
degrad
ubiquitin
target
protein
via
ubiquitin
ligas
activ
import
pathobiolog
mechan
relat
up
lung
diseas
focu
research
inappropri
cellular
proteolysi
valid
therapeut
target
review
contribut
system
variou
lung
diseas
discuss
excit
area
upstarget
drug
develop
pulmonari
diseas
normal
pulmonari
physiolog
disrupt
direct
contact
environ
exposur
potenti
noxiou
inhal
infect
ensu
inflammatori
cell
activ
delic
balanc
normal
homeostasi
tip
toward
inflammatori
injuri
patient
chronic
obstruct
pulmonari
diseas
copd
cystic
fibrosi
acut
respiratori
distress
syndrom
ard
acut
lung
injuri
ali
pneumonia
insight
molecular
pathophysiolog
diseas
greatli
increas
review
highlight
emerg
discoveri
regard
select
regul
protein
degrad
lung
ubiquitin
ub
proteasom
system
up
regul
protein
level
affect
critic
function
lung
cell
ramif
maintain
threaten
vital
organ
mainten
healthi
tissu
requir
stringent
qualiti
control
protein
level
cellular
protein
undergo
tightli
regul
turnov
cell
prevent
improp
activ
unnecessari
accumul
dysfunct
protein
protein
degrad
also
chang
critic
cellular
protein
concentr
respons
chemic
signal
import
cellular
event
mitosi
major
protein
regulatori
system
includ
autophagiclysosom
pathway
preval
up
ubiquitin
coval
interact
protein
wherebi
singl
ubiquitin
attach
one
lysin
monoubiquitin
multipl
lysin
residu
target
multimonoubiquitin
ubiquitin
chain
produc
singl
lysin
residu
polyubiquitin
ubiquitin
contain
seven
lysin
residu
result
eight
differ
interubiquitin
linkag
type
turn
lead
bind
site
ubiquitin
molecul
distinct
branch
ubiquitin
chain
determin
function
substrat
ubiquitin
occur
atpdepend
fashion
elabor
enzymat
cascad
add
ubiquitin
protein
first
ubiquitinactiv
enzym
ubiquitinconjug
enzym
last
specif
target
protein
critic
event
catalyz
ubiquitin
ligas
one
ub
molecul
thu
ad
substrat
monoubiquitin
usual
tag
substrat
endocyt
sort
wherea
polyubiquitin
tag
substrat
recognit
proteasom
often
result
target
protein
degrad
proteasom
protein
complex
compos
one
two
proteolyt
subunit
figur
overal
process
consum
larg
amount
cellular
energi
repres
largest
famili
enzym
present
eukaryot
account
genom
given
physiolog
import
up
system
cellular
tissu
physiolog
failur
up
rare
seen
mutat
protein
identifi
up
ligas
result
human
famili
diseas
includ
angelman
syndrom
parkinson
diseas
von
hippellindau
vhl
syndrom
chang
up
function
implic
disord
cardiovascular
neurolog
pulmonari
system
system
hierarch
one
two
enzym
describ
mammalian
cell
enzym
ligas
describ
target
ubiquitin
degrad
protein
occur
highli
regul
specif
manner
ligas
usual
bind
target
protein
posttransl
modif
harbor
specif
structur
motif
term
degron
two
major
famili
ligas
orchestr
ubiquitin
addit
target
protein
ultim
determin
substanti
shift
cellular
behavior
ring
realli
interest
new
gene
finger
ringrel
protein
compris
largest
famili
whose
member
function
either
independ
monom
dimer
multisubunit
complex
ubiquitin
broad
rang
substrat
hect
homolog
carboxi
terminu
domaincontain
protein
smaller
ligas
famili
whose
member
import
regul
mani
protein
includ
transmembran
surfac
protein
also
famili
ubox
ligas
enzymat
activ
mostli
bridg
catalyt
activ
enzym
facilit
transfer
ubiquitin
target
protein
linear
ubiquitin
complex
lubac
anoth
multisubunit
ligas
polyubiquitin
substrat
sort
andor
degrad
adduct
chain
ub
monom
join
endtoend
lubac
contain
three
import
compon
hemeoxid
ironrespons
elementbind
ubiquitin
hoip
protein
sharpin
shank
multipl
ankyrin
repeat
associ
rh
homolog
protein
ligas
divers
repres
hundr
gene
human
highli
repres
eukaryot
among
ring
multisubunit
ligas
cullinr
famili
anaphasepromot
complexcyclosom
apcc
best
character
largest
famili
cullinr
ligas
protein
scf
famili
canon
multimodul
ubiquitin
complex
often
caus
target
proteasom
degrad
fbox
protein
fbp
interchang
confer
substrat
specif
recognit
posttransl
modifi
degron
motif
within
substrat
via
targetbind
domain
tether
substrat
protein
cullin
protein
scf
complex
via
fbox
domain
fbp
caus
degrad
specif
set
target
protein
uniqu
degron
recognit
sixtyeight
fbp
identifi
human
design
fbxl
contain
leucinerich
domain
fbxw
contain
domain
fbxo
contain
neither
leucinerich
domain
overal
small
fraction
fbp
biolog
known
multipl
laboratori
describ
divers
critic
activ
fbp
physiolog
diseas
one
exampl
ligas
molecular
regul
relat
respir
oxygensens
role
hypoxiainduc
factor
hif
stress
respons
transcript
activ
chemokin
growth
factor
proteas
normoxia
hydroxyl
action
prolyl
hydroxylas
domain
use
oxygen
substrat
hydroxyl
bound
vhl
protein
recruit
ubiquitin
ligas
polyubiquitin
proteasom
degrad
hypoxia
howev
activ
therefor
hydroxyl
decreas
vhl
longer
prevent
activ
transcript
molecular
oxygen
sens
import
normal
embryon
develop
growth
major
pathway
hijack
cancer
cell
limit
local
oxygen
suppli
stabil
augment
local
tumor
growth
metastat
potenti
translat
biomed
research
vhl
protein
signal
axi
describ
initi
vhl
diseas
caus
ineffect
vhl
affect
patient
polycythemia
pulmonari
arteri
hypertens
respiratori
insuffici
attribut
increas
signal
figur
schemat
ubiquitin
ub
proteasom
system
protein
degrad
regul
multistep
process
ubiquitin
load
onto
activ
enzym
atpdepend
fashion
transfer
conjug
enzym
bind
mani
ligas
turn
ubiquitin
sever
target
substrat
protein
ligas
bind
specif
substrat
protein
base
substrat
degron
motif
usual
consist
posttransl
modif
phosphoryl
adduct
via
residu
ub
tag
substrat
sort
lysosom
destruct
proteolyt
cleavag
degrad
ubiquitin
proteasom
linear
ubiquitin
via
residu
linear
ubiquitin
complex
lubac
hoip
sharpin
chang
cellular
local
activ
substrat
includ
rip
nemo
nfkb
signal
hemeoxid
ironrespons
elementbind
ubiquitin
hoip
protein
nemo
nuclear
factorkb
essenti
modul
nfkb
nuclear
factorkb
p
phosphat
rip
receptorinteract
protein
sharpin
shank
multipl
ankyrin
repeat
associ
rh
homolog
domaininteract
protein
ub
ubiqutin
immunoproteasom
extracellular
alveolar
proteasom
proteasom
becom
special
set
infect
inflamm
exampl
tumor
necrosi
factor
tnf
ifn
releas
proinflammatori
cell
lead
convers
element
proteasom
machineri
form
immunoproteasom
gener
peptid
traffick
preferenti
antigenprocess
machineri
ultim
type
major
histocompat
complex
present
lymphocyt
bolster
immun
pathogen
studi
demonstr
presenc
proteasom
outsid
cellular
environ
lung
alveolar
fluid
proteasom
lung
fluid
shown
subunit
cleav
protein
without
requir
ligas
proteinspecif
recognit
ubiquitin
propos
extracellular
proteasom
consequ
cell
lysi
spillag
cellular
content
altern
may
packag
exocytosi
ie
activ
secret
intact
proteasom
regardless
mechan
releas
extracellular
proteasom
increas
set
acut
infect
inflamm
definit
abbrevi
ali
acut
lung
injuri
ccbl
ccasita
blineag
lymphoma
ligas
cct
ctp
phosphocholin
cytidylyltransferas
cf
cystic
fibrosi
cftr
cystic
fibrosi
transmembran
regul
chip
c
terminu
protein
copd
chronic
obstruct
pulmonari
diseas
enac
epitheli
sodium
channel
fbxl
fbxw
fbxo
fbox
protein
contain
leucinerich
domain
domain
neither
leucinerich
domain
respect
histon
hypoxiainduc
hoil
hemeoxid
ubiquitin
ikb
inhibitor
nfkb
receptor
ild
interstiti
lung
diseas
ko
knockout
lysophosphatidylcholin
legionella
pneumophila
strain
pari
fbox
protein
ubiquitin
ligas
muscl
ring
nedd
neural
precursor
cell
express
development
downregul
protein
nfkb
nuclear
factorkb
parvb
parvin
b
pkc
protein
kinas
c
plc
phospholipas
c
rlim
ring
finger
lim
domainbind
protein
ring
finger
protein
membran
sphase
kinaseassoci
snp
singlenucleotid
polymorph
spc
surfact
protein
c
helper
tcell
type
tnf
tumor
necrosi
factor
traf
tnf
receptorassoci
factor
up
ubiquitin
proteasom
system
vhl
von
hippellindau
protein
wt
wild
type
legionella
bacteriaderiv
fbox
protein
adenovirusderiv
ligas
z
part
scf
protein
multisubunit
cullinr
ligas
x
specif
mechan
fulli
character
lung
diseas
may
play
role
antigen
present
activ
immun
extracellular
microb
host
encount
proteasom
dysregul
microbi
pathogen
mechan
pathogen
exploit
host
cell
up
machineri
advantag
exampl
legionella
pneumophila
bacteria
produc
fbp
requir
infect
fbp
bind
compet
substrat
parvb
away
degrad
appar
creat
permiss
cellular
environ
human
adenoviru
creat
two
ligas
protein
caus
degrad
protein
allow
product
viral
protein
genet
materi
without
host
cell
apoptosi
pseudomona
aeruginosa
secret
toxin
cif
vesicl
increas
ubiquitin
degrad
cystic
fibrosi
transmembran
regul
cftr
thu
make
airway
secret
tenaci
coronaviru
caus
sever
acut
respiratori
syndrom
possess
ublik
protein
increas
pathogen
also
proteasom
inhibitor
pretreat
reduc
viral
replic
improv
surviv
mice
implic
role
up
sever
acut
respiratori
syndrom
cystic
fibrosi
cystic
fibrosi
due
insuffici
cftr
cell
surfac
express
caus
impair
chlorid
secret
airway
lumen
reduc
airway
surfac
liquid
conglomer
protein
impair
ciliari
clearanc
enhanc
suscept
infect
cystic
fibrosi
commonli
due
cftr
mutat
posit
phenylalanin
residu
mutant
protein
translat
intercept
endoplasm
reticulum
ligas
chip
ubiquitin
degrad
proteasom
reach
cell
surfac
ctermin
cftr
delet
process
normal
rapidli
shuttl
proteasom
degrad
normal
cftr
membran
express
regul
ligas
ccbl
mediat
ubiquitin
endosom
intern
pulmonari
edema
pulmonari
edema
epitheli
sodium
channel
activ
regul
apic
na
entri
cell
activ
transport
cell
via
nakatpas
critic
mechan
fluid
balanc
lung
addit
regul
protein
concentr
discuss
previous
vhl
protein
also
control
edema
clearanc
hypoxia
mediat
degrad
nakatpas
appear
reactiv
oxygen
speci
particip
regul
nakatpas
via
pkcz
member
lubac
lead
impair
lung
fluid
clearanc
thu
steadi
state
epitheli
sodium
channel
nakatpas
highli
regul
up
critic
maintain
epitheli
function
effect
lung
fluid
balanc
normal
breath
perhap
promin
implic
signal
pulmonari
inflamm
activ
nuclear
factor
k
light
polypeptid
gene
enhanc
b
cell
nfkb
activ
transcript
factor
master
regul
inflamm
lead
express
cytokin
chemokin
adhes
molecul
matrix
metalloproteas
leukocyt
growth
factor
among
other
neg
regul
nfkb
ikb
usual
bind
sequest
nfkb
cytosol
ikb
degrad
ubiquitin
proteasom
via
fbp
btransducin
repeatcontain
protein
btrcp
design
ikb
phosphoryl
recogn
scf
ubiquitin
degrad
leav
nfkb
unrestrict
initi
inflammatori
cascad
ikb
phosphoryl
turn
regul
kinas
activ
ligat
receptor
activ
protein
second
messeng
tnf
receptorassoci
factor
traf
protein
lubac
describ
import
role
regul
inflamm
lubac
known
part
tnf
receptor
signal
complex
particip
signal
process
endtoend
polyubiquitin
tnf
receptor
signal
modul
nemo
appar
increas
signal
transduct
particular
ubiquitin
scheme
lubac
also
target
ligand
sever
tolllik
receptor
tlr
sharpin
mutant
mice
develop
prolif
dermat
patient
mutat
thu
lubac
defici
protract
inflammatori
disord
invas
bacteri
infect
studi
indic
traf
protein
target
scf
ligas
traf
degrad
overexpress
global
suppress
inflammatori
respons
respons
endotoxin
interestingli
anoth
ligas
scf
target
degrad
deplet
cell
increas
decreas
traf
protein
level
blunt
inflammatori
cytokin
releas
vitro
human
polymorph
rel
high
frequenc
among
individu
european
descent
exist
mutant
decreas
ubiquitin
human
polymorph
hospit
sepsi
lower
serum
concentr
inflammatori
cytokin
ligas
itch
caus
degrad
multipl
inflammatori
transcript
factor
signal
molecul
itch
mutat
mice
caus
multiorgan
inflammatori
diseas
pulmonari
interstiti
inflamm
studi
amish
famili
multiorgan
inflammatoryautoimmun
syndrom
character
sever
pneumon
prematur
death
identifi
autosom
recess
mutat
itch
ligas
almost
complet
recapitul
diseas
phenotyp
initi
observ
knockout
mice
appear
checkpoint
function
regul
lpsinduc
inflamm
cytoplasm
suppress
lpsor
tnfinduc
product
proinflammatori
cytokin
inhibit
jnk
cjun
ntermin
kinas
activ
report
hect
domaincontain
ligas
mule
catalyz
tnfainduc
degrad
import
tnfainduc
jnk
activ
cell
death
interestingli
interact
mule
occur
tnfa
independ
pox
viru
zinc
finger
domain
potenti
relev
inflammatori
pathway
pulmonari
infect
asthma
allerg
asthma
antigenspecif
hyperact
helper
tcell
type
immun
respons
caus
airway
obstruct
hyperrespons
bronchodil
immunomodul
includ
steroid
repres
initi
therapi
allergenspecif
immunotherapi
use
promot
immunolog
toler
durabl
symptom
relief
immun
toler
mediat
part
ub
ligas
itch
degrad
phosphoryl
junb
transcript
factor
itch
defici
caus
high
junb
level
increas
product
cytokin
asthma
anim
model
itch
knockout
mice
fail
develop
toler
ovalbumin
antigenspecif
immunomodulatori
therapi
likewis
anoth
ovalbumininduc
asthma
studi
mice
lack
ligas
cblb
immun
toler
disrupt
although
increas
airway
neutrophil
cytokin
ifng
itch
cblb
therefor
seem
play
role
maintain
immun
toler
differ
effector
arm
tcell
system
anoth
ligas
midlin
upregul
antigen
stimul
common
asthma
allergen
hous
dust
mite
target
protein
endogen
inhibitor
cytokin
signal
deactiv
nfkb
henc
small
inhibitori
rna
knockdown
suppress
allerg
inflamm
vivo
mice
vitro
human
lung
cell
copd
tobacco
exposur
smoker
sustain
inflammatori
phenotyp
mani
develop
copd
up
activ
dysregul
set
increas
up
compon
impair
proteasom
activ
cigarett
smoke
administr
epigenet
regul
histon
degrad
up
cigarett
smoke
exposur
secondari
phosphoryl
although
ligas
ring
finger
lim
domainbind
protein
shown
target
system
role
lung
describ
regardless
loss
caus
aberr
inflammatori
gene
transcript
feedforward
inflamm
smoker
level
correl
invers
copd
sever
ali
mani
physiolog
chang
involv
up
tlr
sens
pathogenassoci
molecular
pattern
initi
inflammatori
respons
ligas
cblb
downregul
tlr
signal
cblb
defici
potenti
inflammatori
respons
strong
inflammatori
activ
asthma
ali
receptor
phosphoryl
bound
ubiquitin
scf
caus
up
degrad
ectop
express
decreas
reduc
inflamm
improv
surviv
anim
model
ali
work
deplet
proinflammatori
fbp
target
traf
inhibitor
dispos
restor
protein
level
improv
surviv
lower
cytokin
releas
lessen
inflamm
histolog
mice
pseudomona
lp
model
ard
sever
ard
copd
diaphragmat
peripher
muscl
wast
common
mous
ali
model
display
comorbid
muscl
wast
ligas
muscl
ring
mediat
muscl
breakdown
knockdown
prevent
aliassoci
muscl
wast
mani
compon
within
up
particip
neoplast
process
includ
cancerpromot
fbp
btrcp
sphase
kinaseassoci
also
known
btrcp
disinhibit
inflammatori
nfkb
activ
caus
express
cellactiv
cytokin
growth
factor
proteas
augment
tumor
prolifer
invas
btrcp
also
target
bcatenin
protein
mediat
cell
differenti
wnt
signal
pathway
loss
bcatenin
could
impair
cell
differenti
typic
aggress
malign
howev
tumor
suppressor
facilit
degrad
oncoprotein
destabil
protein
critic
cell
cycl
progress
therebi
inhibit
lung
tumor
cell
growth
lung
cancer
consid
proneoplast
factor
degrad
protect
increas
tissu
invas
studi
show
increas
protein
level
biopsi
specimen
associ
increas
metastasi
moreov
decreas
hi
specimen
robustli
correl
shorter
surviv
pulmonari
surfact
compos
key
surfactantassoci
protein
phospholipid
compon
particip
innat
immun
respons
mainten
alveolar
stabil
lower
surfac
tension
mutat
surfact
protein
c
spc
gene
associ
famili
form
usual
interstiti
pneumonia
pulmonari
fibrosi
spc
process
cell
secret
requir
distinct
step
includ
ubiquitin
ligas
mani
famili
ildassoci
spc
allel
involv
c
terminu
protein
ubiquitin
aggreg
spc
within
perinuclear
inclus
one
mutat
demonstr
defect
traffick
ligas
associ
ctp
phosphocholin
cytidylyltransferas
ccta
essenti
lipogen
enzym
need
surfact
phospholipid
synthesi
ccta
ubiquitin
catalyz
scf
ligas
complex
deplet
stabil
ccta
level
stimul
surfact
biosynthesi
anoth
surfact
enzym
lysophosphatidylcholin
acyltransferas
target
ubiquitin
degrad
btrcp
thu
like
ub
ligas
regul
surfact
compon
modul
lung
homeostasi
first
us
food
drug
administr
fda
approv
drug
target
proteasom
bortezomib
velcad
revers
proteasom
inhibitor
bortezomib
emerg
effect
agent
treatment
multipl
myeloma
malign
previous
link
dismal
prognosi
one
proteasom
inhibitor
approv
fda
use
human
carfilzomib
secondlin
therapi
multipl
myeloma
nonhodgkin
lymphoma
success
bortezomib
establish
proteasom
viabl
target
current
era
drug
develop
report
five
secondgener
proteasom
inhibitor
target
overlap
aspect
cell
signal
vitro
preclin
vivo
target
drug
includ
hematolog
malign
well
solid
tumor
four
agent
enter
phase
clinic
trial
subject
solid
tumor
well
hematolog
malign
neuropathi
classwid
side
effect
proteasom
inhibitor
like
accumul
ubiquitinladen
protein
dorsal
root
ganglia
patient
receiv
therapi
effect
could
avoid
target
factor
upstream
proteasom
figur
first
compound
test
human
target
activ
enzym
requir
activ
cullinr
protein
drug
global
suppress
ubiquitin
cullinr
ligas
includ
scf
ligas
famili
member
other
vitro
activ
agent
reduc
tumor
burden
multipl
model
via
tumor
cell
apoptosi
autophagi
four
phase
clinic
trial
safeti
test
underway
anoth
newli
character
drug
first
smallmolecul
ligas
inhibitor
high
potenc
specif
ligas
drug
suppress
ubiquitin
cullinr
ligas
depend
would
therefor
theoret
highli
overlap
pharmacolog
may
synergist
effect
small
molecul
tosyllarginin
methyl
ester
tame
describ
inhibitor
apc
ligas
requir
dismantl
spindl
assembl
checkpoint
complet
mitot
divis
tame
prevent
deplet
cyclin
therebi
lead
mitot
arrest
metaphas
next
put
select
target
ubiquitinationproteasom
pathway
target
individu
subunit
ligas
although
drug
activ
enter
clinic
trial
signific
research
area
fbpspecif
inhibitor
first
report
ligasetarget
drug
identifi
discov
smallmolecul
interrog
scf
complex
abil
displac
scf
phosphodegron
yeast
system
molecul
antagon
scf
scf
complex
relat
fbp
human
ortholog
anoth
small
molecul
inhibit
scf
target
ctermin
apag
domain
bacterialik
domain
found
two
gene
human
compound
show
potent
blockad
activ
robust
decreas
traf
downstream
inflammatori
mediat
releas
endotoxinstimul
human
blood
monocyt
effect
reduc
inflamm
lung
injuri
preclin
model
sepsi
ali
demonstr
target
specif
inhibitor
singl
fbp
requir
test
success
farreach
implic
may
set
stage
new
genu
antiinflammatori
drug
summari
up
lung
biolog
fundament
area
research
discoveri
activ
mani
ligas
fbp
remain
unknown
mani
discoveri
await
us
year
come
howev
becom
clear
protein
process
via
up
play
central
role
princip
type
lung
diseas
tabl
along
newli
describ
mechan
pathobiolog
come
signific
advanc
strategi
intervent
expand
arsen
potenti
therapi
although
treatment
upstarget
medic
thu
far
limit
hematolog
malign
antiinflammatori
agent
act
up
compon
may
becom
commonplac
next
decad
especi
select
compound
fewer
side
effect
identifi
difficult
ascertain
innov
impact
medicin
evolut
upstarget
therapi
howev
seem
new
gener
drug
act
import
system
becom
mainstay
therapi
diseas
author
disclosur
avail
text
articl
wwwatsjournalsorg
figur
drug
target
ubiquitinproteasom
system
up
bortezomib
carfilzomib
us
food
drug
administrationapprov
proteasom
inhibitor
block
cleavag
substrat
protein
proteasom
upstream
inhibitor
block
ubiquitin
inhibit
cullinr
ligas
inhibit
enzym
activ
cullinr
ligas
respect
temper
cell
prolifer
tame
block
apc
ligas
activ
caus
mitot
arrest
fbox
specif
inhibitor
block
yeast
fbox
proteindepend
ubiquitin
substrat
protein
activ
human
fbp
prevent
scf
substrat
ubiquitin
degrad
protein
enhanc
scf
depend
traf
degrad
decreas
inflamm
apc
anaphasepromot
complex
fbp
fbox
protein
fbxl
fbxo
fbox
protein
contain
leucinerich
domain
neither
leucinerich
domain
respect
nedd
neural
precursor
cell
express
development
downregul
protein
p
phosphat
ring
realli
interest
new
gene
scf
protein
tame
tosyllarginin
methyl
ester
traf
tumor
necrosi
factor
receptorassoci
factor
ub
ubiquitin
